High-performance liquid chromatographic assay for the simultaneous determination of lansoprazole enantiomers and metabolites in human liver microsomes

Add time:07/18/2019    Source:sciencedirect.com

In this study, a simple, sensitive and enantioselective HPLC method was developed for the simultaneous determination of lansoprazole enantiomers: a proton pump inhibitor, and its major metabolites: 5-hydroxylansoprazole and lansoprazole sulfone in human liver microsomes. After extraction from the microsomal incubation mixture with a diethyl ether–dichloromethane (7:3, v/v) mixture, analytes were measured by reversed-phase HPLC on a Chiralcel® OD-R column. Detection was made using an ultraviolet absorbance detector set at a wavelength of 285 nm. The mobile phase consisted of a methanol–water (75:25, v/v) mixture. At a flow-rate of 0.5 ml/min, the total run time was 35 min. The limit of quantification for both lansoprazole enantiomers was 0.25 μM and for the metabolites 0.13 μM. The method is suitable for the analysis of lansoprazole enantiomers and its metabolites from human microsomal liver incubations.

We also recommend Trading Suppliers and Manufacturers of 5-HYDROXY LANSOPRAZOLE (cas 131926-98-2). Pls Click Website Link as below: cas 131926-98-2 suppliers

Prev:Development and validation of an enantioselective and chemoselective HPLC method using a Chiralpak IA column to simultaneously quantify (R)-(+)- and (S)-(−)-lansoprazole enantiomers and related impurities
Next:Determination of lansoprazole and two of its metabolites by liquid–liquid extraction and automated column-switching high-performance liquid chromatography: application to measuring CYP2C19 activity)